sunitinib,nivolumab,ipilimumab,cabozantinib
ipsen,bms,pfizer
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nivolumab', 'renal,(-adrenal)', 'nivo', 'cabozantinib', 'check,mate,9er', 'cabometyx', 'ipsen']
cabozantinib (cabometyx ) in combination with nivolumab shows durable survival benefits at over three years follow-up in first-line advanced #renalcellcarcinoma. data to be presented at #gu23. details on urotoday &gt; #checkmate9er 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology